Translational Development Acquisition Corp. Ordinary Shares (NASDAQ:TDAC) — Market Cap & Net Worth
Market Cap & Net Worth: Translational Development Acquisition Corp. Ordinary Shares (TDAC)
Translational Development Acquisition Corp. Ordinary Shares (NASDAQ:TDAC) has a market capitalization of $209.89 Million ($209.89 Million) as of September 15, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #16474 globally and #3916 in its home market, demonstrating a 0.18% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Translational Development Acquisition Corp. Ordinary Shares's stock price $10.87 by its total outstanding shares 19308802 (19.31 Million). Also see total assets of Translational Development Acquisition Co for a full breakdown of the balance sheet.
Translational Development Acquisition Corp. Ordinary Shares Market Cap History: 2025 to 2026
Translational Development Acquisition Corp. Ordinary Shares's market capitalization history from 2025 to 2026. Data shows growth from $202.55 Million to $209.89 Million (0.00% CAGR). Also see Translational Development Acquisition Co cash flow conversion for how efficiently the company converts equity into cash flow.
Translational Development Acquisition Corp. Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Translational Development Acquisition Corp. Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check TDAC stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of TDAC by Market Capitalization
Companies near Translational Development Acquisition Corp. Ordinary Shares in the global market cap rankings as of September 15, 2026. Review Translational Development Acquisition Co (TDAC) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Translational Development Acquisition Corp. Ordinary Shares by market ranking:
- Twenty One Capital, Inc. (NYSE:XXI): Ranked #6166 globally with a market cap of $2.01 Billion USD.
- Drugs Made In America Acquisition II Corp. Ordinary Shares (NASDAQ:DMII): Ranked #11029 globally with a market cap of $647.19 Million USD.
- Ares Acquisition Corporation II (NYSE:AACT): Ranked #11495 globally with a market cap of $587.05 Million USD.
- Voyager Acquisition Corp (NASDAQ:VACH): Ranked #11910 globally with a market cap of $541.25 Million USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #6166 | Twenty One Capital, Inc. | NYSE:XXI | $2.01 Billion | $5.79 |
| #11029 | Drugs Made In America Acquisition II Corp. Ordinary Shares | NASDAQ:DMII | $647.19 Million | $10.18 |
| #11495 | Ares Acquisition Corporation II | NYSE:AACT | $587.05 Million | $9.49 |
| #11910 | Voyager Acquisition Corp | NASDAQ:VACH | $541.25 Million | $24.79 |
Translational Development Acquisition Corp. Ordinary Shares Historical Marketcap From 2025 to 2026
Between 2025 and today, Translational Development Acquisition Corp. Ordinary Shares's market cap moved from $202.55 Million to $ 209.89 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $209.89 Million | +3.62% |
| 2025 | $202.55 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 15th, 2026 the market cap of Translational Development Acquisition Corp. Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $209.89 Million USD |
| MoneyControl | $209.89 Million USD |
| MarketWatch | $209.89 Million USD |
| marketcap.company | $209.89 Million USD |
| Reuters | $209.89 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Translational Development Acquisition Corp. Ordinary Shares
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.